Business Description
OncoSil Medical Ltd
ISIN : AU000000OSL3
Description
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 64.3 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -14.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 17.8 | |||||
| 3-Year EPS without NRI Growth Rate | 20.6 | |||||
| 3-Year FCF Growth Rate | 14.5 | |||||
| 3-Year Book Growth Rate | -55 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -70.05 | |||||
| 12-1 Month Momentum % | -50.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.26 | |||||
| Quick Ratio | 3.26 | |||||
| Cash Ratio | 2.32 | |||||
| Days Sales Outstanding | 204.97 | |||||
| Days Payable | 342.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -46.9 | |||||
| Shareholder Yield % | -18.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -192.07 | |||||
| Operating Margin % | -2529.4 | |||||
| Net Margin % | -2304.45 | |||||
| FCF Margin % | -2089.03 | |||||
| ROE % | -191.14 | |||||
| ROA % | -145.12 | |||||
| ROIC % | -2776.43 | |||||
| ROC (Joel Greenblatt) % | -4385.15 | |||||
| ROCE % | -189.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 7 | |||||
| EV-to-EBIT | -2.33 | |||||
| EV-to-EBITDA | -2.35 | |||||
| EV-to-Revenue | 53.73 | |||||
| EV-to-FCF | -2.57 | |||||
| Earnings Yield (Greenblatt) % | -42.98 | |||||
| FCF Yield % | -33.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OncoSil Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.319 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 81.25 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.000643 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -50.88 | ||
| 52-Week Range (€) | 0.019 - 0.11 | ||
| Shares Outstanding (Mil) | 797.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OncoSil Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OncoSil Medical Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
OncoSil Medical Ltd Frequently Asked Questions
What is OncoSil Medical Ltd(FRA:N6A)'s stock price today?
The current price of FRA:N6A is €0.02. The 52 week high of FRA:N6A is €0.11 and 52 week low is €0.02.
When is next earnings date of OncoSil Medical Ltd(FRA:N6A)?
The next earnings date of OncoSil Medical Ltd(FRA:N6A) is .
Does OncoSil Medical Ltd(FRA:N6A) pay dividends? If so, how much?
OncoSil Medical Ltd(FRA:N6A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers